Stay updated on Nivolumab for High-Risk Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk Prostate Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A 'Results Submitted' section was added and the 'No Results Posted' note was removed.
    Difference
    0.2%
    Check dated 2026-04-01T10:20:33.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page adds the Prostate cancer tag and related topics such as MedlinePlus Genetics. The site revision is updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-25T03:13:34.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-10T15:33:06.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. This appears to be a site version update and does not affect study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-02-17T03:27:28.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Addition: Revision: v3.4.1 and deletions including the funding notice, related topics (Prostate cancer, MedlinePlus Genetics), and the older revision reference (v3.4.0). These changes do not affect the study details, endpoints, locations, or eligibility on this page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-09T22:30:36.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A government funding notice banner was added at the top of the page. It states that information may not be up to date and that transactions may not be processed, with links for current status at cc.nih.gov and opm.gov.
    Difference
    0.4%
    Check dated 2026-02-02T19:40:46.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.